Michael Weinkowitz specializes in complex products liability cases and mass tort on a national scale, and is a partner at Levin Sedran & Berman, a nationally recognized firm with a reputation for taking on multi-district, complex litigation. Quickly earning distinction for exceptional litigation skills, persuasive collaboration, and litigation management, Mr. Weinkowitz has been appointed to Plaintiff’s Steering Committees and served Chair of Discovery and Law and Briefing Committees in several of the US’s largest complex actions.Representing tens of thousands of plaintiffs since 2002, Mr. Weinkowitz has dedicated his career to holding global corporations accountable and played a critical role in bringing billions of dollars in settlements to fruition. He is a gifted litigator and has the ability to influence collaboration, even in the face of competing attorney priorities, and has extensive experience in taking depositions of whistleblowers and top executives. Mr. Weinkowitz’s work has proved foundational from discovery to settlement negotiations and, above all, frequently served as a locus for case advancement. Mr. Weinkowitz has substantial professional experience in complex products liability cases and has served, or is serving as a Court-appointed Executive, Steering or major committee member in complex cases, including In re: Social Media Adolescent Addiction Prod. Liab. Litig. MDL 3047 (N.D. CA)(Plaintiff Leadership Committee, Co-Chair Discovery Committee); In re: Juul Prod. Liab. Litig. MDL 2913 (N.D. CA) (Plaintiffs Steering Committee member, Co-chair of Discovery Committee and Chair of the Law and Briefing Committee); In re: Xarelto (Phila. C.C.P. No. 2349) (Co-Lead and Member of Joint State-Federal Settlement Committee); In re: Xarelto Prod. Liab. Litig., MDL 2592 (E.D. LA) (Federal-State Liaison); In re Tylenol Prod. Liab. Litig., MDL 2436 (Liaison Counsel and Chair of both the Discovery and Law and Briefing Committees. He served as member of the Settlement Team that negotiated the global settlement that was reached); In re: Yaz, Yasmin, Ocella Prod. Liab. Litig. (Phila. C.C.P. No. 1307) (Co-Lead and Member of Negotiating Plaintiffs Committee); In re: Fresenius Granuflo/Naturalyte Dialysate Prod. Liab. Litig. MDL 2428 (D.MA) (Discovery Co-Chair); In re: Pradaxa Prod. Liab. Litig., MDL 2385 (S.D.IL) (Plaintiff Steering Committee member). Mr. Weinkowitz has also served on various Discovery and Science Committees including in In re: Vioxx Product Liability Litigation, MDL No. 1657 (E.D. LA).